Media Release

Australian leadership in global effort against cervical cancer

September 26th, 2024

Published: September 26th, 2024

Pacific Friends of Global Health strongly endorses Prime Minister Anthony Albanese’s announcement of the Quad Cancer Moonshot initiative, a groundbreaking agreement between Australia, the United States, India, and Japan to save lives and prevent cervical cancer in the Indo-Pacific region.

“Australia’s commitment to eliminating cervical cancer, both domestically and in our region, is a testament to our nation’s scientific prowess and dedication to global health equity,” said Professor Brendan Crabb, Chair of Pacific Friends of Global Health. “This reinforces Australia’s position as a world leader in the fight against this preventable disease.”

The commitment expands the Elimination Partnership in the Indo-Pacific for Cervical Cancer Program, pledging $16.5 million from the Australian Government, complemented by a $13.1 million contribution from the Minderoo Foundation. It supports the roll out of HPV vaccine programs in Papua New Guinea, Malaysia, Timor-Leste, Solomon Islands, Vanuatu, Tuvalu, Fiji, Nauru, and beyond.

“This builds upon Australia’s rich history of medical innovation, particularly the development of the HPV vaccine by Professor Ian Frazer at the University of Queensland,” Professor Crabb said. “It’s heartening to see Australia take a leading role in ensuring that this life-saving technology reaches those who need it most in our region.”

The disparity in cervical cancer mortality rates between Australia and its Pacific neighbours underscores the urgency of this initiative. Women in some Pacific nations face up to 13 times higher risk of dying from cervical cancer compared to women in Australia.

Pacific Friends of Global Health commends the collaborative approach of the Quad Cancer Moonshot, which exemplifies the power of international cooperation in addressing global health challenges. The partnership between government and philanthropy, as demonstrated by the involvement of both the Gavi, the Vaccine Alliance and the Minderoo Foundation, sets a powerful example for future health initiatives.

“We look forward to seeing the positive impact of this program in reducing the burden of cervical cancer across the Indo-Pacific,” Professor Crabb concluded. “This announcement not only saves lives but also contributes to broader development goals, empowering women and girls to reach their full potential, free from the threat of cervical cancer.”

Contact: Nick Lucchinelli 0422229032